Reciprocal regulation of NO signaling and TXNIP expression in humans: Impact of aging and ramipril therapy☆

作者: Aaron L Sverdlov , Wai PA Chan , Nathan EK Procter , Yuliy Y Chirkov , Doan TM Ngo

DOI: 10.1016/J.IJCARD.2013.07.159

关键词:

摘要: Abstract Background Impaired tissue responsiveness to nitric oxide (NO) occurs in many cardiovascular diseases as well with advanced age and is a correlate of poor outcomes. This phenomenon results from oxidative stress, NO "scavenging" dysfunction soluble guanylate cyclase (sGC). Thioredoxin-interacting protein (TXNIP) major intracellular regulator inflammatory activation redox but its interactions NO/sGC are poorly understood. We have now evaluated the relationship between platelet TXNIP expression function axis subjects varying during therapy ramipril. Methods & Young (n=42) aging (n=49) underwent evaluation content. Aging additionally had measurements routine biochemistry. Platelet content was greater (376±33units) compared younger (289±13units; p Conclusions increases aging, varies inversely NO, diminishes rapidly following treatment These data suggest that TXNIP-induced stress may be critical modulator resistance fundamental basis for disease. Analogously suppression can potentially utilized an index restoration homeostasis.

参考文章(65)
Scott R. Willoughby, Sharmalar Rajendran, Wai P. Chan, Nathan Procter, Sue Leslie, Elizabeth A. Liberts, Tamila Heresztyn, Yuliy Y. Chirkov, John D. Horowitz, Ramipril Sensitizes Platelets to Nitric Oxide: Implications for Therapy in High-Risk Patients Journal of the American College of Cardiology. ,vol. 60, pp. 887- 894 ,(2012) , 10.1016/J.JACC.2012.01.066
Rajesh Kanna, John D Horowitz, Yuliy Y Chirkov, Sunil Chandy, Kumaril Mishra, Andrew S Holmes, Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis. Journal of Heart Valve Disease. ,vol. 15, pp. 28- 33 ,(2006)
Doan TM Ngo, Irene Stafford, Aaron L Sverdlov, Weier Qi, Ronald D Wuttke, Yuan Zhang, Darren J Kelly, Helen Weedon, Malcolm D Smith, Jennifer A Kennedy, John D Horowitz, None, Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations British Journal of Pharmacology. ,vol. 162, pp. 722- 732 ,(2011) , 10.1111/J.1476-5381.2010.01084.X
Takashi Okamoto, Toshifumi Tetsuka, Nobuo Matsui, Tetsuji Katoh, Kazuko Uno, Shinichi Yoshida, Involvement of Thioredoxin in Rheumatoid Arthritis: Its Costimulatory Roles in the TNF-α-Induced Production of IL-6 and IL-8 from Cultured Synovial Fibroblasts Journal of Immunology. ,vol. 163, pp. 351- 358 ,(1999)
Richard A Anderson, Gethin R Ellis, L. Marc Evans, Keith Morris, Yuri Y Chirkov, John D Horowitz, Simon K Jackson, Alan Rees, Malcolm J Lewis, Michael P Frenneaux, Platelet nitrate responsiveness in fasting and postprandial type 2 diabetes Diabetes and Vascular Disease Research. ,vol. 2, pp. 88- 93 ,(2005) , 10.3132/DVDR.2005.015
Parth Patwari, William A. Chutkow, Kiersten Cummings, Valerie L. R. M. Verstraeten, Jan Lammerding, Eric R. Schreiter, Richard T. Lee, Thioredoxin-independent Regulation of Metabolism by the α-Arrestin Proteins Journal of Biological Chemistry. ,vol. 284, pp. 24996- 25003 ,(2009) , 10.1074/JBC.M109.018093
Yuliy Y. Chirkov, Michele De Sciscio, Aaron L. Sverdlov, Sue Leslie, Peter R. Sage, John D. Horowitz, Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure. Cardiovascular Drugs and Therapy. ,vol. 24, pp. 131- 137 ,(2010) , 10.1007/S10557-010-6233-0
Xiaonan Li, Yuanyuan Rong, Mei Zhang, Xing Li Wang, Scott A. LeMaire, Joseph S. Coselli, Yun Zhang, Ying H. Shen, Up-regulation of Thioredoxin Interacting Protein (Txnip) by p38 MAPK and FOXO1 Contributes to the Impaired Thioredoxin Activity and Increased ROS in Glucose- treated Endothelial Cells Biochemical and Biophysical Research Communications. ,vol. 381, pp. 660- 665 ,(2009) , 10.1016/J.BBRC.2009.02.132